Evidence map›Paper›PMID 38595257›Full record

ArticleBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences2024

[Molecular biology analysis of 2 rare RhD variant individuals with

Peng Wang, Ziyao Yang, Meng Wang, Wei Wang, Aizhi Li

Open access · greenAbstract readCase ReportsEnglish Abstract
PubMed Full text at PMC
In one paragraph

Article in Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Peng WangDepartment of Transfusion, Peking University First Hospital, Beijing 100034, China.
Ziyao YangDepartment of Transfusion, Peking University First Hospital, Beijing 100034, China.
Meng WangDepartment of Transfusion, Peking University First Hospital, Beijing 100034, China.
Wei WangDepartment of Transfusion, Peking University First Hospital, Beijing 100034, China.
Aizhi LiDepartment of Transfusion, Peking University First Hospital, Beijing 100034, China.
Peking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Rh blood grouping system is a critical standardized test in transfusion medicine, especially for the cases related to haemolytic transfusion reactions and neonatal haemolytic disease caused by clinical RhD blood group incompatibility. In the present case report, we presented two cases with the uncommon

Indexed as

Blood Group AntigensRh-Hr Blood-Group SystemAllelesGenotypeHumansInfant, NewbornMolecular BiologyPhenotypeBlood Group AntigensRh-Hr Blood-Group SystemRho(D) antigenAllelesGenotyping techniquesRh-Hr blood-group systemSerology

Identifiers

PMID38595257
PMCPMC11004959
OpenAlexW4394762986

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.